Neurological consequences of COVID-19 are being reported in 36-84% of COVID-19 patients. Why such a big percentage range? Because the tools being used in the majority of clinics and hospitals to confirm the presence of neurological consequences are subjective – based on patient self-reporting or observable symptoms.
VoxNeuro’s neurotechnology can support patients and healthcare teams by confirming if patients are suffering from neurological consequences of COVID-19.
Unlike subjective brain assessment tools, VoxNeuro’s Cognitive Health Assessments™ measure brain health using brain biomarkers.
Learn more about the neurological consequences of COVID-19.